Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Express Scripts
Federal Trade Commission
Fish and Richardson
Dow
Moodys
AstraZeneca
Julphar
QuintilesIMS

Generated: January 21, 2019

DrugPatentWatch Database Preview

Siga Technologies Company Profile

« Back to Dashboard

What is the competitive landscape for SIGA TECHNOLOGIES, and what generic alternatives to SIGA TECHNOLOGIES drugs are available?

SIGA TECHNOLOGIES has one approved drug.

There are six US patents protecting SIGA TECHNOLOGIES drugs.

There are fifty-nine patent family members on SIGA TECHNOLOGIES drugs in twenty countries.

Summary for Siga Technologies
International Patents:59
US Patents:6
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Siga Technologies

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Siga Technologies TPOXX tecovirimat CAPSULE;ORAL 208627-001 Jul 13, 2018 RX Yes Yes 8,039,504 ➤ Try a Free Trial Y ➤ Try a Free Trial
Siga Technologies TPOXX tecovirimat CAPSULE;ORAL 208627-001 Jul 13, 2018 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Siga Technologies TPOXX tecovirimat CAPSULE;ORAL 208627-001 Jul 13, 2018 RX Yes Yes 8,530,509 ➤ Try a Free Trial Y ➤ Try a Free Trial
Siga Technologies TPOXX tecovirimat CAPSULE;ORAL 208627-001 Jul 13, 2018 RX Yes Yes 8,124,643 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Siga Technologies TPOXX tecovirimat CAPSULE;ORAL 208627-001 Jul 13, 2018 RX Yes Yes 7,737,168 ➤ Try a Free Trial ➤ Try a Free Trial
Siga Technologies TPOXX tecovirimat CAPSULE;ORAL 208627-001 Jul 13, 2018 RX Yes Yes 9,339,466 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Siga Technologies TPOXX tecovirimat CAPSULE;ORAL 208627-001 Jul 13, 2018 RX Yes Yes 8,802,714 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Siga Technologies Drugs

Country Document Number Estimated Expiration
South Korea 20150092354 ➤ Try a Free Trial
Peru 09442017 ➤ Try a Free Trial
Canada 2866037 ➤ Try a Free Trial
China 103068232 ➤ Try a Free Trial
Canada 2685153 ➤ Try a Free Trial
Japan 2007521273 ➤ Try a Free Trial
Australia 2004249250 ➤ Try a Free Trial
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKinsey
QuintilesIMS
Mallinckrodt
Federal Trade Commission
Accenture
Julphar
Healthtrust
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.